Skip to Content
Merck
  • Assessment of a pro-healing stent in an animal model of early neoatherosclerosis.

Assessment of a pro-healing stent in an animal model of early neoatherosclerosis.

Scientific reports (2020-05-20)
Philipp Nicol, Christoph Lutter, Anna Bulin, Maria Isabel Castellanos, Tobias Lenz, Petra Hoppmann, Anna Lena Lahmann, Roisin Colleran, Kristina Euller, Kristin Steigerwald, Stefanie Neubauer, Florian Rechenmacher, Beatrice Stefanie Ludwig, Michael Weinmüller, Garry Kerch, Liang Guo, Qi Cheng, Eduardo Acampado, Tobias Koppara, Horst Kessler, Michael Joner
ABSTRACT

Neoatherosclerosis represents an accelerated manifestation of atherosclerosis in nascent neointima after stenting, associated with adverse events. We investigated whether improved reendothelialization using RGD-coated stents results in diminished vascular permeability and reduced foam cell formation compared to standard DES in atherosclerotic rabbits. Neointimal foam cell formation was induced in rabbits (n = 7). Enhanced endothelial integrity in RGD-coated stents resulted in decreased vascular permeability relative to DES, which was further confirmed by SEM and TEM. Cell culture experiments examined the effect of everolimus on endothelial integrity. Increasing concentrations of everolimus resulted in a dose-dependent decrease of endothelial cell junctions and foam cell transformation of monocytes, confirming the relevance of endothelial integrity in preventing permeability of LDL. Incomplete endothelial integrity was confirmed as a key factor of neointimal foam cell formation following stent implantation. Pro-healing stent coatings may facilitate reendothelialization and reduce the risk of neoatherosclerosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
PEPTITE-2000®